These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5481827)

  • 1. [The rheumatoid rosette (R. R.) phenomenon in chronic evolutive polyarthritis. (C. E. P.). II. Significance; value in the diagnosis of serum-negative cases].
    Delrieu F; Bach JF; Delbarre F
    Presse Med (1893); 1970 Nov; 78(49):2175-9. PubMed ID: 5481827
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of detection of the rheumatoid rosette phenomenon in seronegative polyarthritis (apropos of 44 cases)].
    Waltzing P; Bloch-Michel H
    Ann Med Interne (Paris); 1971; 122(6):777-81. PubMed ID: 5113450
    [No Abstract]   [Full Text] [Related]  

  • 3. [Colloidal gold sulfate in the therapy of chronic evolutive polyarthritis].
    Colamussi V; Longhini C; Vallini A; Antonioli G; Bazzanini G
    Minerva Med; 1967 Sep; 58(74):3137-58. PubMed ID: 6051031
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of 100 cases of sero-negative (rheumatoid?) polyarthritis and 100 cases of sero-positive rheumatoid polyarthritis (R.P.)].
    Coste F; Delbarre F; Amor B; Bontous D; Broulhet H; Guiraudon C; Menkès C; Saporta L
    Sem Hop; 1968 Mar; 44(12):777-92. PubMed ID: 4300523
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of inflammatory activity in primary chronic polyarthritis].
    Hartmann F; Rohde J; Schmidt A
    Z Rheumaforsch; 1969; 28(7):263-70. PubMed ID: 5344695
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dissociation of the rheumatoid factor and the anti-Gm(a) activity of the serum in chronic evolutive polyarthritis].
    Audran R; Matte C; Moullec J; Steinbuch M
    Bibl Haematol; 1965; 23():418-22. PubMed ID: 4160124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gm properties in rheumatoid diseases with special reference to chronic progressive polyarthritis. II. Anti-Gm factors n rheumatoid diseases].
    Neumann W; Barthel E; Tanner E; Seidel K
    Z Gesamte Inn Med; 1970 Jun; 25(11):500-5. PubMed ID: 5523394
    [No Abstract]   [Full Text] [Related]  

  • 8. [Laboratory diagnosis of rheumatoid arthritis].
    Ravetta A
    Arch Sci Med (Torino); 1970; 127(10-12):333-42. PubMed ID: 5519849
    [No Abstract]   [Full Text] [Related]  

  • 9. [IgA rheumatoid factor and prognosis in chronic polyarthritis].
    Wagner E; Hofmann E; Feyertag J; Dunky A
    Wien Med Wochenschr; 1999; 149(19-20):548-9. PubMed ID: 10637964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technical problems in population studies of rheumatoid arthritis (p.c.p.-progressive chronic polyarthritis)--development and current status. 2. Screening instruments and epidemiologic material criteria].
    Leistner K
    Z Arztl Fortbild (Jena); 1973 Oct; 67(20):1049-54. PubMed ID: 4774650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative value of 2 simple technics for the diagnosis of chronic evolutive polyarthritis. (Survey bearing on 250 cases)].
    VINCENT V; MARTIN C; VINCENT P
    Ann Biol Clin (Paris); 1963; 21():297-302. PubMed ID: 13997352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatment in progressive chronic polyarthritis. Medical physiological evaluation methods and results].
    Josenhans G; Binzus G
    Verh Dtsch Ges Rheumatol; 1969; 1():316-22. PubMed ID: 5403651
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunologic reactivity in infectious non-specific (evolutive) polyarthritis].
    Sheffer AA; Sheffer IA
    Ter Arkh; 1968 Dec; 40(12):33-6. PubMed ID: 5746538
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-evolutive characteristics of rheumatoid polyarthritis in the aged].
    Duţu A; Parasca I; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(6):503-8. PubMed ID: 6136074
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
    Tian X; Bi LQ; Li ZG
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathology of non-specific infectious (rheumatoid) polyarthritis].
    Piaĭ LT
    Ter Arkh; 1967 Jul; 39(7):19-24. PubMed ID: 4180505
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serological findings in progressive chronic polyarthritis].
    Römer R
    Beitr Rheumatol; 1973; 20():56-66. PubMed ID: 4775428
    [No Abstract]   [Full Text] [Related]  

  • 19. Serology and immunoglobulin profile in rheumatoid arthritis.
    Adhya S; Chakraborty G; Hajra B; Bhattacharya S; Sikdar PK; Sinha S; Banerjee PP; Ghosh E; Chakraborty P
    Indian J Pathol Microbiol; 1998 Jan; 41(1):43-7. PubMed ID: 9581076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
    Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
    J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.